EP2408749
Himnuleiðnistillimótarar slímseigjusjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.3.2010EP published:
16.5.2018EP application number:
10710748.4
EP translation filed:
14.8.2018Grant published:
15.9.2018EPO information:
European Patent Register
Max expiry date:
18.3.2030Expiry date:
18.3.2027Next due date:
31.3.2027
Title:
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Timeline
Today
19.3.2010EP application
16.5.2018EP Publication
14.8.2018Translation submitted
15.9.2018Registration published
18.3.2027Expires
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, 02210, Boston, MA, US
Inventor
Name:
YANG, XiaoqingAddress:
San DiegoCA, US
Name:
HADIDA RUAH, Sara, S.Address:
La JollaCA, US
Name:
GROOTENHUIS, Peter, D.J.Address:
San DiegoCA, US
Name:
VAN GOOR, Fredrick, F.Address:
San DiegoCA, US
Name:
BOTFIELD, Martyn, C.Address:
ConcordMA, US
Name:
ZLOKARNIK, GregorAddress:
La JollaCA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
162130 PDate:
20.3.2009Country:
US
Classification
Categories:
C07D 215/233, A61K 31/47, A61P 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 4.3.2019
Expires: 18.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 3.3.2020
Expires: 18.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 2.3.2021
Expires: 18.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 2.3.2022
Expires: 18.3.2023
Payer: Patice ehf.
Number: 14
Paid: 9.3.2023
Expires: 18.3.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 6.3.2024
Expires: 18.3.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 13.2.2025
Expires: 18.3.2026
Payer: Árnason Faktor ehf.
Number: 17
Paid: 20.3.2026
Expires: 18.3.2027
Payer: Árnason Faktor ehf.